Barinthus Biotherapeutics plc (BRNS)
Total Valuation
BRNS has a market cap or net worth of $92.63 million. The enterprise value is -$36.48 million.
Market Cap | 92.63M |
Enterprise Value | -36.48M |
Important Dates
The last earnings date was Wednesday, March 20, 2024, before market open.
Earnings Date | Mar 20, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BRNS has 38.64 million shares outstanding.
Shares Outstanding | 38.64M |
Owned by Insiders (%) | 3.69% |
Owned by Institutions (%) | 47.85% |
Float | 18.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 115.50 |
Forward PS | 68.11 |
PB Ratio | 0.50 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.46, with a Debt / Equity ratio of 0.07.
Current Ratio | 12.46 |
Quick Ratio | n/a |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2,728.36 |
Financial Efficiency
Return on equity (ROE) is -35.20% and return on invested capital (ROIC) is -42.01%.
Return on Equity (ROE) | -35.20% |
Return on Assets (ROA) | -30.80% |
Return on Capital (ROIC) | -42.01% |
Revenue Per Employee | $7,495 |
Profits Per Employee | -$685,486 |
Employee Count | 107 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | -3.08M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.73% in the last 52 weeks. The beta is -0.48, so BRNS's price volatility has been lower than the market average.
Beta (1Y) | -0.48 |
52-Week Price Change | +6.73% |
50-Day Moving Average | 2.68 |
200-Day Moving Average | 2.75 |
Relative Strength Index (RSI) | 39.38 |
Average Volume (30 Days) | 14,777 |
Short Selling Information
Short Interest | 11,890 |
Short Previous Month | 12,286 |
Short % of Shares Out | 0.05% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.58 |
Income Statement
In the last 12 months, BRNS had revenue of $802,000 and -$73.35 million in losses. Loss per share was -$1.91.
Revenue | 802,000 |
Gross Profit | 802,000 |
Operating Income | -83.91M |
Pretax Income | -76.42M |
Net Income | -73.35M |
EBITDA | -69.64M |
EBIT | -76.39M |
Loss Per Share | -$1.91 |
Balance Sheet
The company has $142.09 million in cash and $12.98 million in debt, giving a net cash position of $129.11 million or $3.34 per share.
Cash & Cash Equivalents | 142.09M |
Total Debt | 12.98M |
Net Cash | 129.11M |
Net Cash Per Share | $3.34 |
Equity / Book Value | 186.78M |
Book Value Per Share | 4.83 |
Working Capital | 144.31M |
Cash Flow
In the last 12 months, operating cash flow was -$50.93 million and capital expenditures -$5.41 million, giving a free cash flow of -$56.34 million.
Operating Cash Flow | -50.93M |
Capital Expenditures | -5.41M |
Free Cash Flow | -56.34M |
FCF Per Share | -$1.47 |
Margins
Gross margin is 100.00%, with operating and profit margins of -10,463.09% and -9,145.51%.
Gross Margin | 100.00% |
Operating Margin | -10,463.09% |
Pretax Margin | -9,528.93% |
Profit Margin | -9,145.51% |
EBITDA Margin | -8,682.92% |
EBIT Margin | -9,525.44% |
FCF Margin | -7,024.69% |
Dividends & Yields
BRNS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.57% |
Shareholder Yield | -0.57% |
Earnings Yield | -79.18% |
FCF Yield | -60.82% |
Analyst Forecast
The average price target for BRNS is $8.00, which is 236.13% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.00 |
Price Target Difference | 236.13% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 12.69% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BRNS has an Altman Z-Score of 0.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.5 |
Piotroski F-Score | 1 |